Drug intelligence / Profile preview

Aftolimor

Development stage
Unknown
Lead developer
LIMOR de Colombia
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Aftolimor is a veterinary vaccine developed and manufactured by LIMOR (Laboratorios Limor de Colombia) for the prevention and control of foot-and-mouth disease (FMD) in cattle. It is an inactivated viral vaccine designed to elicit a protective immune response against the Foot-and-Mouth Disease Virus (FMDV), specifically targeting serotypes common in the Andean region, such as serotypes O and A. The vaccine is typically administered as part of mandatory national vaccination campaigns to maintain FMD-free status in livestock populations. It is formulated with an oil-based adjuvant to enhance immunogenicity and provide sustained protection. Aftolimor is a critical component of the livestock health infrastructure in Colombia, where it is used to protect cattle from the highly contagious FMDV, which can have significant economic impacts on the agricultural sector.

Brand names
Aftolimor
Other names
Vacuna contra la Fiebre Aftosa
02

Targets

Foot-and-mouth disease virus serotype A24 Cruzeiro structural polyproteinFMDV antigen (Foot-and-mouth disease virus antigens)

Beyond the preview

Go deeper on Aftolimor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aftolimor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call